Mount Prospect, IL, United States of America

Louis J Bedell

This inventor holds 18 USPTO granted patents and 1 EPO patent, primarily in Protease Inhibitors. Top assignees: Pharmacia Corporation, Angus Chemical Company, Decode Genetics Ehf. Active years: 1990-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Louis J Bedell. Retrieved from https://idiyas.com/inventor/louis-j-bedell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 44.4


Average Co-Inventor Count = 9.2

ph-index = 6

Forward Citations = 93(Granted Patents)


Location History:

  • Mount Prospect, IL (US) (1991)
  • Mt. Prospect, IL (US) (1990 - 2006)
  • Prospect Heights, IL (US) (2004 - 2013)

Company Filing History:


Years Active: 1990-2013

Loading Chart...
Loading Chart...
Areas of Expertise:
Protease Inhibitors
Hydroxamic Acids
Sulfonyl Compounds
Matrix Metalloprotease
Biaryl Heterocycles
Piperidinyl Compounds
Aromatic Sulfones
Thioaryl Sulfonamides
Divalent Aryl Compounds
Nitroalkanes
Nitroalcohols
18 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Louis J. Bedell

Introduction

Louis J. Bedell is a prominent inventor based in Mount Prospect, Illinois, known for his significant contributions to the field of pharmaceuticals. With a total of 18 patents to his name, his work primarily focuses on developing innovative solutions for treating inflammatory diseases and disorders.

Latest Patents

One of Bedell's latest patents is a groundbreaking invention concerning biaryl substituted heterocycle inhibitors of leukotriene A4 hydrolase (LTA4H). This chemical genus is pivotal for the treatment, prevention, and prophylaxis of inflammatory diseases. The compounds developed carry a general formula that holds promise for improving therapeutic outcomes in patients suffering from various inflammation-related conditions.

Career Highlights

Throughout his career, Louis J. Bedell has worked with notable organizations, including Pharmacia Corporation and G.D. Searle & Company. His extensive experience in these companies has enabled him to explore and innovate within the pharmaceutical landscape, leading to the formulation of key therapeutic agents.

Collaborations

Bedell has collaborated with several esteemed professionals in his field, including Thomas E. Barta and Daniel Paul Becker. These collaborations have likely fostered a dynamic exchange of ideas and advancements, contributing to the successful development of his patented technologies.

Conclusion

Louis J. Bedell's work exemplifies the spirit of innovation in the pharmaceutical industry. His discoveries, particularly in the area of inflammatory disease treatments, showcase the impact that dedicated inventors can have on improving health outcomes. As he continues to evolve in his field, the implications of his patented inventions may lead to transformative advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…